PRDX2 and carcinoma: PRDX2 was in the cytoplasm of carcinoma cells in all 5 CCA cases (Fig. 2B). BGN was expressed in the cytoplasm and/or nucleus of carcinoma cells in 2 (40%) of 5 CCA cases (Fig. 3C).